Anuradha J Phadke, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 15 years
- University of Cincinnati College of Medicine, 2011
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Phadke’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A122095 · Current
Licensed to practise in California · since 2012 · expires 2028-07-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$27,812
Medicare paid this office $27,812 for 187 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 71 | $6,014 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 82 | $5,989 | $73 |
| Short return visit (20+ min) | 57 | $2,985 | $48 |
| Return visit (30+ min) | 23 | $2,425 | $62 |
| Long return visit (40+ min) | 24 | $2,355 | $74 |
See all 9 services
| Return visit (30+ min) | 71 | $6,014 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 82 | $5,989 | $73 |
| Short return visit (20+ min) | 57 | $2,985 | $48 |
| Return visit (30+ min) | 23 | $2,425 | $62 |
| Long return visit (40+ min) | 24 | $2,355 | $74 |
| Long return visit (40+ min) | 15 | $2,121 | $88 |
| Short return visit (20+ min) | 22 | $1,571 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 70 | $1,348 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 25 | $704 | $15 |
Who their Medicare patients are
187 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 10% · Women 56% · Also on Medicaid 31% · Health risk score 1.32. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 67% · Diabetes 41% · Chronic kidney disease 27% · Coronary heart disease 24% · Cancer 16% · Depression 16% · Atrial fibrillation 11% · Heart failure 10% · COPD 10% · Stroke 7%.
The office billed $178,541, Medicare allowed $39,445 and paid $27,812; for 546 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 187 | 546 | 74 | 1.32 | $178,541 | $27,812 |
| 2023 | 192 | 404 | 73 | 1.35 | $148,779 | $23,339 |
| 2022 | 189 | 366 | 72 | 1.31 | $148,113 | $23,251 |
| 2021 | 186 | 425 | 73 | 1.37 | $152,876 | $27,863 |
| 2020 | 171 | 391 | 70 | 1.45 | $100,598 | $22,739 |
| 2019 | 234 | 449 | 70 | 1.37 | $54,305 | $25,926 |
| 2018 | 212 | 369 | 71 | 1.63 | $45,147 | $22,087 |
| 2017 | 177 | 316 | 71 | 1.48 | $51,830 | $16,642 |
| 2016 | 235 | 499 | 70 | 1.54 | $95,525 | $29,919 |
| 2015 | 64 | 74 | 69 | 1.98 | $14,609 | $4,728 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 85 | $7,930 | $56 |
| Short return visit (20+ min) | 87 | $5,175 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $5,095 | $61 |
| Long return visit (40+ min) | 35 | $3,433 | $70 |
2022: 7 services
| Return visit (30+ min) | 98 | $8,632 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 72 | $4,390 | $61 |
| Short return visit (20+ min) | 58 | $3,392 | $51 |
| Long return visit (40+ min) | 24 | $2,362 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,294 | $86 |
| New patient visit (45+ min) | 11 | $1,176 | $107 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,004 | $91 |
2021: 7 services
| Return visit (30+ min) | 101 | $11,264 | $62 |
| Short return visit (20+ min) | 70 | $4,106 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $3,320 | $68 |
| Long return visit (40+ min) | 24 | $2,183 | $68 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $2,114 | $92 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $1,739 | $134 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $991 | $58 |
2020: 6 services
| Return visit (30+ min) | 60 | $7,254 | $66 |
| Short return visit (20+ min) | 89 | $5,147 | $41 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,135 | $70 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $1,828 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,732 | $144 |
| Return visit (30+ min) | 14 | $1,189 | $85 |
2019: 3 services
| Return visit (30+ min) | 104 | $10,643 | $62 |
| Short return visit (20+ min) | 159 | $9,587 | $42 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,541 | $141 |
2018: 5 services
| Return visit (30+ min) | 72 | $6,664 | $65 |
| Short return visit (20+ min) | 119 | $6,060 | $40 |
| Return visit (30+ min) | 32 | $2,614 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,965 | $140 |
| Short return visit (20+ min) | 34 | $1,613 | $45 |
2017: 3 services
| Short return visit (20+ min) | 140 | $8,143 | $38 |
| Return visit (30+ min) | 47 | $3,866 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,909 | $139 |
2016: 5 services
| Short return visit (20+ min) | 167 | $10,705 | $42 |
| Return visit (30+ min) | 105 | $10,304 | $59 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $3,012 | $201 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,753 | $138 |
| New patient visit (45+ min) | 18 | $1,830 | $102 |
2015: 3 services
| Short return visit (20+ min) | 31 | $1,515 | $45 |
| New patient visit (45+ min) | 15 | $1,486 | $99 |
| Return visit (30+ min) | 19 | $1,406 | $70 |
Medicaid work
$2,319 in 2024
Medicaid paid $2,319 for 79 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 54 | $2,001 |
| Short return visit (20+ min) | 25 | $318 |
| 2024 | 79 | 2 | 14 | $2,319 |
| 2023 | 16 | 1 | 16 | $362 |
| 2022 | 13 | 1 | 13 | $26 |
| 2021 | 24 | 1 | 12 | $406 |
| 2020 | 27 | 1 | 13 | $259 |
| 2019 | 67 | 1 | 14 | $613 |
| 2018 | 29 | 1 | 14 | $273 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 16 | $362 |
2022
| Short return visit (20+ min) | 13 | $26 |
2021
| Return visit (30+ min) | 24 | $406 |
2020
| Short return visit (20+ min) | 27 | $259 |
2019
| Short return visit (20+ min) | 67 | $613 |
2018
| Short return visit (20+ min) | 29 | $273 |
Drugs they prescribed that Part D paid
$413,358
Pharmacies billed $413,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (87 of 2,230) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 17% of their opioid prescriptions.
1,786 generic and 425 brand-name prescriptions · $413,358 in drug cost · 20 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 62 | $66,036 | $1,065 |
| Jardiance | 32 | $48,533 | $1,517 |
| Eliquis | 26 | $35,984 | $1,384 |
| Mounjaro | 23 | $24,666 | $1,072 |
| Trulicity | 15 | $17,692 | $1,179 |
See all 56 drugs
| Ozempic | 62 | $66,036 | $1,065 |
| Jardiance | 32 | $48,533 | $1,517 |
| Eliquis | 26 | $35,984 | $1,384 |
| Mounjaro | 23 | $24,666 | $1,072 |
| Trulicity | 15 | $17,692 | $1,179 |
| Farxiga | 11 | $5,909 | $537 |
| Lidocaine | 17 | $5,771 | $339 |
| Fiasp Flextouch | 11 | $3,151 | $286 |
| Estradiol | 23 | $2,916 | $127 |
| Gabapentin | 53 | $1,645 | $31 |
| Pregabalin | 38 | $1,631 | $43 |
| Celecoxib | 28 | $1,547 | $55 |
| Atorvastatin | 145 | $1,519 | $10 |
| Hydrocodone-Acetaminophen | 65 | $1,355 | $21 |
| Rosuvastatin | 95 | $1,281 | $13 |
| Valsartan | 13 | $848 | $65 |
| Famotidine | 28 | $764 | $27 |
| Albuterol Sulfate Hfa | 16 | $761 | $48 |
| Ezetimibe | 18 | $739 | $41 |
| Zolpidem | 20 | $694 | $35 |
| Amlodipine Besylate | 95 | $646 | $7 |
| Levothyroxine | 58 | $642 | $11 |
| Losartan | 74 | $619 | $8 |
| Omeprazole | 25 | $599 | $24 |
| Tamsulosin | 39 | $593 | $15 |
| Lisinopril | 59 | $439 | $7 |
| Duloxetine | 14 | $415 | $30 |
| Pravastatin | 11 | $375 | $34 |
| Alendronate | 44 | $352 | $8 |
| Pantoprazole | 36 | $349 | $10 |
| Potassium Chloride | 13 | $322 | $25 |
| Diltiazem 24hr Er (Cd) | 12 | $310 | $26 |
| Metoprolol | 26 | $310 | $12 |
| Metformin | 45 | $302 | $7 |
| Escitalopram | 11 | $287 | $26 |
| Montelukast | 15 | $283 | $19 |
| Donepezil | 19 | $259 | $14 |
| Finasteride | 12 | $240 | $20 |
| Simvastatin | 20 | $224 | $11 |
| Chlorthalidone | 17 | $176 | $10 |
| Clonazepam | 32 | $174 | $5 |
| Hydrocortisone | 14 | $172 | $12 |
| Clopidogrel | 30 | $171 | $6 |
| Hydralazine | 12 | $161 | $13 |
| Metformin Hcl Er | 20 | $155 | $8 |
| Hydrochlorothiazide | 34 | $150 | $4 |
| Fluticasone Propionate | 16 | $133 | $8 |
| Glipizide | 23 | $131 | $6 |
| Alprazolam | 12 | $120 | $10 |
| Venlafaxine Hcl Er | 12 | $112 | $9 |
| Furosemide | 11 | $108 | $10 |
| Spironolactone | 11 | $100 | $9 |
| Allopurinol | 18 | $87 | $5 |
| Glipizide Er | 11 | $87 | $8 |
| Atenolol | 12 | $53 | $4 |
| Triamcinolone Acetonide | 12 | $50 | $4 |
Year by year
| 2024 | 2,230 | 171 | 4% (87) | 19% | $413,358 |
| 2023 | 2,299 | 222 | 5% (118) | 16% | $353,154 |
| 2022 | 2,408 | 224 | 5% (111) | 15% | $333,190 |
| 2021 | 2,543 | 255 | 6% (161) | 17% | $375,260 |
| 2020 | 2,587 | 285 | 6% (147) | 16% | $321,926 |
| 2019 | 2,720 | 344 | 5% (144) | 16% | $274,989 |
| 2018 | 2,498 | 319 | 6% (144) | 17% | $305,394 |
| 2017 | 2,058 | 257 | 6% (116) | 17% | $195,782 |
| 2016 | 1,900 | 237 | 6% (120) | 16% | $158,362 |
| 2015 | 142 | 51 | 11% (15) | None | $8,709 |
| 2014 | 12 | None | None | None | $778 |
| 2013 | 15 | None | None | None | $1,341 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 61 drugs
| Jardiance | 24 | $32,368 | $1,349 |
| Ozempic | 27 | $28,503 | $1,056 |
| Eliquis | 15 | $25,014 | $1,668 |
| Trulicity | 12 | $15,977 | $1,331 |
| Lidocaine | 36 | $10,549 | $293 |
| Farxiga | 11 | $10,534 | $958 |
| Anoro Ellipta | 13 | $7,544 | $580 |
| Januvia | 12 | $6,958 | $580 |
| Basaglar Kwikpen U-100 | 12 | $4,197 | $350 |
| Rosuvastatin | 84 | $3,390 | $40 |
| Pregabalin | 23 | $3,216 | $140 |
| Atorvastatin | 172 | $2,578 | $15 |
| Gabapentin | 45 | $1,693 | $38 |
| Estradiol | 11 | $1,569 | $143 |
| Losartan | 98 | $1,545 | $16 |
| Hydrocodone-Acetaminophen | 67 | $1,545 | $23 |
| Tamsulosin | 53 | $1,494 | $28 |
| Ventolin Hfa | 12 | $1,490 | $124 |
| Celecoxib | 18 | $1,381 | $77 |
| Duloxetine | 28 | $1,159 | $41 |
| Famotidine | 24 | $1,131 | $47 |
| Lacosamide | 16 | $1,113 | $70 |
| Albuterol Sulfate Hfa | 19 | $1,104 | $58 |
| Potassium Chloride | 21 | $1,078 | $51 |
| Ezetimibe | 16 | $969 | $61 |
| Omeprazole | 25 | $832 | $33 |
| Escitalopram | 15 | $785 | $52 |
| Lisinopril | 57 | $713 | $13 |
| Venlafaxine Hcl Er | 11 | $704 | $64 |
| Levothyroxine | 53 | $651 | $12 |
| Amlodipine Besylate | 76 | $645 | $8 |
| Metformin | 42 | $591 | $14 |
| Simvastatin | 34 | $589 | $17 |
| Diclofenac | 17 | $578 | $34 |
| Clonazepam | 34 | $563 | $17 |
| Finasteride | 19 | $488 | $26 |
| Metoprolol | 14 | $452 | $32 |
| Donepezil | 19 | $451 | $24 |
| Allopurinol | 20 | $419 | $21 |
| Alendronate | 31 | $419 | $14 |
| Ketoconazole | 14 | $393 | $28 |
| Pantoprazole | 21 | $379 | $18 |
| Montelukast | 11 | $372 | $34 |
| Metformin Hcl Er | 24 | $368 | $15 |
| Hydrocortisone | 22 | $358 | $16 |
| Zolpidem | 14 | $330 | $24 |
| Metoprolol | 31 | $296 | $10 |
| Fluticasone Propionate | 20 | $287 | $14 |
| Chlorthalidone | 15 | $268 | $18 |
| Clopidogrel | 19 | $255 | $13 |
| Ciclopirox | 11 | $207 | $19 |
| Risperidone | 13 | $163 | $13 |
| Nortriptyline | 14 | $161 | $11 |
| Atenolol | 19 | $134 | $7 |
| Triamcinolone Acetonide | 14 | $113 | $8 |
| Furosemide | 14 | $109 | $8 |
| Morphine Sulfate Er | 12 | $101 | $8 |
| Alprazolam | 13 | $86 | $7 |
| Tramadol | 16 | $73 | $5 |
| Paroxetine | 12 | $65 | $5 |
| Hydrochlorothiazide | 18 | $64 | $4 |
2022: 57 drugs
| Jardiance | 29 | $36,460 | $1,257 |
| Eliquis | 19 | $29,292 | $1,542 |
| Lidoderm | 11 | $25,791 | $2,345 |
| Novolog Mix 70-30 Flexpen | 18 | $17,996 | $1,000 |
| Xarelto | 14 | $10,505 | $750 |
| Farxiga | 12 | $9,781 | $815 |
| Novolog Flexpen | 13 | $7,853 | $604 |
| Symbicort | 14 | $6,509 | $465 |
| Lidocaine | 24 | $4,977 | $207 |
| Rosuvastatin | 68 | $3,597 | $53 |
| Gabapentin | 84 | $3,432 | $41 |
| Pregabalin | 13 | $2,968 | $228 |
| Enoxaparin | 13 | $2,508 | $193 |
| Atorvastatin | 200 | $2,386 | $12 |
| Hydrocodone-Acetaminophen | 63 | $1,589 | $25 |
| Valsartan | 14 | $1,482 | $106 |
| Celecoxib | 29 | $1,461 | $50 |
| Duloxetine | 24 | $1,338 | $56 |
| Ventolin Hfa | 13 | $1,281 | $99 |
| Losartan | 103 | $1,057 | $10 |
| Omeprazole | 48 | $962 | $20 |
| Tamsulosin | 38 | $828 | $22 |
| Allopurinol | 37 | $801 | $22 |
| Ezetimibe | 20 | $776 | $39 |
| Diclofenac | 21 | $767 | $37 |
| Famotidine | 27 | $738 | $27 |
| Levothyroxine | 53 | $717 | $14 |
| Amlodipine Besylate | 92 | $706 | $8 |
| Metformin | 74 | $571 | $8 |
| Potassium Chloride | 15 | $566 | $38 |
| Fluticasone Propionate | 27 | $559 | $21 |
| Lisinopril | 59 | $483 | $8 |
| Nortriptyline | 23 | $428 | $19 |
| Chlorthalidone | 20 | $415 | $21 |
| Montelukast | 15 | $410 | $27 |
| Clonazepam | 41 | $392 | $10 |
| Donepezil | 23 | $374 | $16 |
| Alendronate | 34 | $337 | $10 |
| Metoprolol | 19 | $320 | $17 |
| Esomeprazole Magnesium | 13 | $312 | $24 |
| Metformin Hcl Er | 24 | $291 | $12 |
| Carvedilol | 14 | $268 | $19 |
| Simvastatin | 39 | $266 | $7 |
| Finasteride | 15 | $261 | $17 |
| Zolpidem | 24 | $217 | $9 |
| Venlafaxine Hcl Er | 13 | $208 | $16 |
| Olmesartan Medoxomil | 15 | $199 | $13 |
| Hydrochlorothiazide | 30 | $143 | $5 |
| Glipizide | 19 | $126 | $7 |
| Tramadol | 16 | $106 | $7 |
| Trazodone | 20 | $105 | $5 |
| Atenolol | 16 | $91 | $6 |
| Triamcinolone Acetonide | 11 | $89 | $8 |
| Spironolactone | 13 | $86 | $7 |
| Furosemide | 15 | $71 | $5 |
| Risperidone | 12 | $59 | $5 |
| Paroxetine | 12 | $52 | $4 |
2021: 66 drugs
| Jardiance | 41 | $40,015 | $976 |
| Trulicity | 28 | $32,899 | $1,175 |
| Xarelto | 31 | $23,709 | $765 |
| Januvia | 12 | $18,438 | $1,537 |
| Symbicort | 12 | $7,071 | $589 |
| Lidocaine | 30 | $4,802 | $160 |
| Gabapentin | 84 | $3,948 | $47 |
| Flovent Hfa | 11 | $3,709 | $337 |
| Famotidine | 19 | $3,086 | $162 |
| Atorvastatin | 181 | $2,906 | $16 |
| Hydrocodone-Acetaminophen | 86 | $2,237 | $26 |
| Rosuvastatin | 47 | $2,021 | $43 |
| Diclofenac | 30 | $1,915 | $64 |
| Pregabalin | 16 | $1,794 | $112 |
| Metformin Er Osmotic | 13 | $1,712 | $132 |
| Losartan | 94 | $1,239 | $13 |
| Levothyroxine | 57 | $1,231 | $22 |
| Omeprazole | 68 | $1,207 | $18 |
| Valsartan | 14 | $1,029 | $73 |
| Tamsulosin | 43 | $1,011 | $24 |
| Bupropion Xl | 12 | $908 | $76 |
| Duloxetine | 11 | $893 | $81 |
| Albuterol Sulfate Hfa | 23 | $892 | $39 |
| Amlodipine Besylate | 89 | $877 | $10 |
| Metformin | 93 | $870 | $9 |
| Nortriptyline | 18 | $851 | $47 |
| Metoprolol | 27 | $663 | $25 |
| Ezetimibe | 13 | $637 | $49 |
| Losartan-Hydrochlorothiazide | 11 | $636 | $58 |
| Allopurinol | 23 | $617 | $27 |
| Potassium Chloride | 26 | $579 | $22 |
| Clopidogrel | 20 | $579 | $29 |
| Montelukast | 17 | $528 | $31 |
| Finasteride | 22 | $524 | $24 |
| Celecoxib | 11 | $491 | $45 |
| Clonazepam | 44 | $475 | $11 |
| Lisinopril | 45 | $461 | $10 |
| Oxybutynin Chloride Er | 11 | $459 | $42 |
| Simvastatin | 43 | $457 | $11 |
| Pantoprazole | 13 | $440 | $34 |
| Alendronate | 44 | $418 | $9 |
| Zolpidem | 26 | $399 | $15 |
| Fluticasone Propionate | 21 | $379 | $18 |
| Metformin Hcl Er | 16 | $372 | $23 |
| Carvedilol | 15 | $286 | $19 |
| Glipizide Er | 12 | $282 | $24 |
| Chlorthalidone | 12 | $235 | $20 |
| Azelastine | 11 | $231 | $21 |
| Nystatin | 16 | $223 | $14 |
| Morphine Sulfate Er | 15 | $221 | $15 |
| Tramadol | 24 | $217 | $9 |
| Esomeprazole Magnesium | 13 | $204 | $16 |
| Trazodone | 28 | $199 | $7 |
| Spironolactone | 16 | $194 | $12 |
| Metoprolol | 19 | $190 | $10 |
| Olmesartan Medoxomil | 12 | $174 | $14 |
| Hydrochlorothiazide | 48 | $166 | $3 |
| Furosemide | 29 | $116 | $4 |
| Glipizide | 18 | $106 | $6 |
| Atenolol | 18 | $105 | $6 |
| Alprazolam | 12 | $86 | $7 |
| Risperidone | 12 | $79 | $7 |
| Paroxetine | 12 | $59 | $5 |
| Diazepam | 11 | $52 | $5 |
| Alcohol Swab | 11 | $32 | $3 |
| Benztropine Mesylate | 13 | $27 | $2 |
2020: 59 drugs
| Jardiance | 21 | $22,588 | $1,076 |
| Trulicity | 16 | $17,183 | $1,074 |
| Januvia | 11 | $16,014 | $1,456 |
| Xarelto | 13 | $13,791 | $1,061 |
| Gabapentin | 95 | $4,904 | $52 |
| Oxycontin | 14 | $4,596 | $328 |
| Lidocaine | 18 | $4,302 | $239 |
| Atorvastatin | 194 | $3,978 | $21 |
| Diclofenac | 34 | $2,545 | $75 |
| Rosuvastatin | 42 | $2,489 | $59 |
| Esomeprazole Magnesium | 15 | $2,252 | $150 |
| Losartan | 102 | $1,930 | $19 |
| Levetiracetam | 22 | $1,614 | $73 |
| Levothyroxine | 71 | $1,572 | $22 |
| Hydrocodone-Acetaminophen | 75 | $1,551 | $21 |
| Omeprazole | 65 | $1,193 | $18 |
| Pregabalin | 16 | $1,180 | $74 |
| Ventolin Hfa | 16 | $1,157 | $72 |
| Duloxetine | 24 | $1,100 | $46 |
| Amlodipine Besylate | 129 | $1,087 | $8 |
| Chlorthalidone | 23 | $1,057 | $46 |
| Tamsulosin | 34 | $880 | $26 |
| Metoprolol | 41 | $837 | $20 |
| Oxybutynin Chloride Er | 13 | $786 | $60 |
| Potassium Chloride | 27 | $781 | $29 |
| Metformin | 82 | $699 | $9 |
| Pantoprazole | 19 | $648 | $34 |
| Lisinopril | 64 | $580 | $9 |
| Clonazepam | 37 | $577 | $16 |
| Simvastatin | 45 | $575 | $13 |
| Finasteride | 22 | $558 | $25 |
| Allopurinol | 27 | $552 | $20 |
| Alendronate | 41 | $477 | $12 |
| Trazodone | 29 | $449 | $15 |
| Nortriptyline | 15 | $444 | $30 |
| Mirtazapine | 11 | $442 | $40 |
| Ezetimibe | 16 | $424 | $27 |
| Clopidogrel | 16 | $335 | $21 |
| Zolpidem | 26 | $334 | $13 |
| Hydralazine | 11 | $333 | $30 |
| Nystatin | 19 | $331 | $17 |
| Glipizide | 20 | $321 | $16 |
| Tramadol | 29 | $308 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $301 | $25 |
| Hydrochlorothiazide | 57 | $291 | $5 |
| Spironolactone | 13 | $264 | $20 |
| Fluticasone Propionate | 28 | $245 | $9 |
| Warfarin | 13 | $235 | $18 |
| Sertraline | 18 | $218 | $12 |
| Furosemide | 32 | $213 | $7 |
| Atenolol | 27 | $199 | $7 |
| Venlafaxine Hcl Er | 14 | $176 | $13 |
| Montelukast | 14 | $174 | $12 |
| Morphine Sulfate Er | 11 | $166 | $15 |
| Triamcinolone Acetonide | 14 | $118 | $8 |
| Ramipril | 11 | $105 | $10 |
| Alprazolam | 16 | $93 | $6 |
| Risperidone | 12 | $81 | $7 |
| Paroxetine | 12 | $64 | $5 |
2019: 60 drugs
| Jardiance | 18 | $20,595 | $1,144 |
| Xarelto | 15 | $19,522 | $1,301 |
| Trulicity | 11 | $13,961 | $1,269 |
| Eliquis | 15 | $9,502 | $633 |
| Gabapentin | 97 | $3,932 | $41 |
| Atorvastatin | 193 | $3,416 | $18 |
| Ventolin Hfa | 40 | $2,862 | $72 |
| Levothyroxine | 92 | $2,223 | $24 |
| Rosuvastatin | 23 | $1,989 | $86 |
| Hydrocodone-Acetaminophen | 70 | $1,629 | $23 |
| Esomeprazole Magnesium | 13 | $1,627 | $125 |
| Losartan | 86 | $1,260 | $15 |
| Lidocaine | 16 | $1,220 | $76 |
| Duloxetine | 24 | $1,182 | $49 |
| Amlodipine Besylate | 136 | $1,132 | $8 |
| Levetiracetam | 18 | $1,059 | $59 |
| Chlorthalidone | 21 | $1,039 | $49 |
| Metformin | 112 | $965 | $9 |
| Diltiazem 24hr Er (Cd) | 19 | $925 | $49 |
| Potassium Chloride | 30 | $924 | $31 |
| Omeprazole | 74 | $920 | $12 |
| Diclofenac | 24 | $875 | $36 |
| Lisinopril | 75 | $830 | $11 |
| Synthroid | 12 | $811 | $68 |
| Tamsulosin | 35 | $737 | $21 |
| Bupropion Xl | 12 | $730 | $61 |
| Simvastatin | 56 | $615 | $11 |
| Montelukast | 34 | $604 | $18 |
| Metoprolol | 29 | $564 | $19 |
| Allopurinol | 26 | $537 | $21 |
| Pantoprazole | 18 | $535 | $30 |
| Clonazepam | 36 | $517 | $14 |
| Nortriptyline | 14 | $502 | $36 |
| Alendronate | 50 | $488 | $10 |
| Finasteride | 21 | $486 | $23 |
| Nystatin | 28 | $462 | $17 |
| Fluticasone Propionate | 37 | $458 | $12 |
| Pravastatin | 16 | $441 | $28 |
| Ketoconazole | 12 | $439 | $37 |
| Trazodone | 25 | $399 | $16 |
| Losartan-Hydrochlorothiazide | 17 | $396 | $23 |
| Naltrexone | 12 | $366 | $30 |
| Tramadol | 35 | $343 | $10 |
| Furosemide | 32 | $321 | $10 |
| Carvedilol | 28 | $321 | $11 |
| Hydrochlorothiazide | 51 | $237 | $5 |
| Warfarin | 14 | $231 | $17 |
| Triamcinolone Acetonide | 19 | $220 | $12 |
| Atenolol | 27 | $211 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $190 | $16 |
| Prednisone | 11 | $168 | $15 |
| Metformin Hcl Er | 15 | $147 | $10 |
| Acyclovir | 11 | $139 | $13 |
| Sertraline | 12 | $135 | $11 |
| Polyethylene Glycol 3350 | 13 | $134 | $10 |
| Glipizide | 17 | $106 | $6 |
| Azithromycin | 12 | $98 | $8 |
| Zolpidem | 16 | $95 | $6 |
| Risperidone | 12 | $71 | $6 |
| Paroxetine | 12 | $53 | $4 |
2018: 57 drugs
| Lidoderm | 16 | $18,074 | $1,130 |
| Xarelto | 17 | $15,185 | $893 |
| Lyrica | 11 | $11,469 | $1,043 |
| Advair Diskus | 12 | $8,751 | $729 |
| Humulin 70-30 | 11 | $4,839 | $440 |
| Atorvastatin | 145 | $3,559 | $25 |
| Gabapentin | 74 | $2,691 | $36 |
| Duloxetine | 14 | $2,117 | $151 |
| Omega-3 Acid Ethyl Esters | 16 | $1,993 | $125 |
| Hydrocodone-Acetaminophen | 78 | $1,803 | $23 |
| Levothyroxine | 82 | $1,589 | $19 |
| Levetiracetam | 16 | $1,283 | $80 |
| Ketoconazole | 18 | $1,129 | $63 |
| Rosuvastatin | 15 | $1,038 | $69 |
| Pantoprazole | 33 | $1,004 | $30 |
| Metformin | 121 | $975 | $8 |
| Voltaren | 16 | $882 | $55 |
| Amlodipine Besylate | 109 | $881 | $8 |
| Losartan-Hydrochlorothiazide | 22 | $872 | $40 |
| Losartan | 68 | $836 | $12 |
| Ventolin Hfa | 14 | $784 | $56 |
| Omeprazole | 56 | $646 | $12 |
| Lisinopril | 84 | $597 | $7 |
| Potassium Chloride | 24 | $585 | $24 |
| Tamsulosin | 28 | $559 | $20 |
| Metoprolol | 30 | $549 | $18 |
| Alendronate | 80 | $531 | $7 |
| Fluticasone Propionate | 37 | $525 | $14 |
| Pravastatin | 17 | $520 | $31 |
| Simvastatin | 45 | $498 | $11 |
| Polyethylene Glycol 3350 | 12 | $492 | $41 |
| Hydralazine | 17 | $477 | $28 |
| Clonazepam | 38 | $446 | $12 |
| Methotrexate | 11 | $425 | $39 |
| Isosorbide Mononitrate Er | 15 | $418 | $28 |
| Allopurinol | 20 | $369 | $18 |
| Naltrexone | 11 | $335 | $30 |
| Finasteride | 20 | $312 | $16 |
| Clopidogrel | 13 | $301 | $23 |
| Zolpidem | 25 | $249 | $10 |
| Atenolol | 30 | $235 | $8 |
| Tramadol | 38 | $231 | $6 |
| Hydrochlorothiazide | 44 | $230 | $5 |
| Montelukast | 12 | $213 | $18 |
| Triamterene-Hydrochlorothiazid | 17 | $202 | $12 |
| Spironolactone | 14 | $189 | $13 |
| Warfarin | 12 | $188 | $16 |
| Glipizide | 29 | $187 | $6 |
| Metformin Hcl Er | 15 | $141 | $9 |
| Furosemide | 27 | $129 | $5 |
| Carvedilol | 17 | $127 | $7 |
| Lamotrigine | 13 | $126 | $10 |
| Famotidine | 12 | $85 | $7 |
| Methadone | 11 | $78 | $7 |
| Alprazolam | 11 | $75 | $7 |
| Metoprolol | 11 | $67 | $6 |
| Prednisone | 11 | $58 | $5 |
2017: 46 drugs
| Spiriva | 17 | $15,622 | $919 |
| Lidoderm | 11 | $13,296 | $1,209 |
| Xarelto | 17 | $11,518 | $678 |
| Lantus Solostar | 11 | $11,197 | $1,018 |
| Vesicare | 21 | $7,288 | $347 |
| Advair Diskus | 11 | $6,669 | $606 |
| Victoza 2-Pak | 12 | $6,128 | $511 |
| Lyrica | 11 | $5,930 | $539 |
| Incruse Ellipta | 12 | $3,968 | $331 |
| Atorvastatin | 147 | $2,984 | $20 |
| Gabapentin | 60 | $2,684 | $45 |
| Duloxetine | 16 | $1,933 | $121 |
| Levothyroxine | 68 | $1,618 | $24 |
| Tamsulosin | 37 | $1,399 | $38 |
| Methotrexate | 12 | $1,150 | $96 |
| Metformin | 110 | $1,068 | $10 |
| Hydrocodone-Acetaminophen | 57 | $1,019 | $18 |
| Valsartan | 17 | $930 | $55 |
| Polyethylene Glycol 3350 | 21 | $928 | $44 |
| Losartan | 72 | $851 | $12 |
| Pantoprazole | 25 | $825 | $33 |
| Omeprazole | 61 | $789 | $13 |
| Amlodipine Besylate | 90 | $784 | $9 |
| Metoprolol | 23 | $621 | $27 |
| Fluticasone Propionate | 30 | $587 | $20 |
| Lisinopril | 65 | $571 | $9 |
| Simvastatin | 39 | $547 | $14 |
| Potassium Chloride | 14 | $499 | $36 |
| Allopurinol | 21 | $472 | $22 |
| Clopidogrel | 23 | $465 | $20 |
| Isosorbide Mononitrate Er | 11 | $429 | $39 |
| Clonazepam | 33 | $336 | $10 |
| Atenolol | 44 | $290 | $7 |
| Hydralazine | 16 | $286 | $18 |
| Hydrochlorothiazide | 39 | $252 | $6 |
| Warfarin | 12 | $236 | $20 |
| Paroxetine | 15 | $188 | $13 |
| Alendronate | 37 | $180 | $5 |
| Tramadol | 26 | $178 | $7 |
| Metoprolol | 22 | $146 | $7 |
| Glipizide | 25 | $139 | $6 |
| Metformin Hcl Er | 11 | $129 | $12 |
| Famotidine | 14 | $127 | $9 |
| Furosemide | 24 | $97 | $4 |
| Lamotrigine | 11 | $67 | $6 |
| Alprazolam | 12 | $64 | $5 |
2016: 49 drugs
| Januvia | 14 | $9,674 | $691 |
| Lidocaine | 22 | $9,653 | $439 |
| Lyrica | 13 | $9,045 | $696 |
| Myrbetriq | 14 | $8,490 | $606 |
| Lantus Solostar | 14 | $7,793 | $557 |
| Victoza 2-Pak | 12 | $5,779 | $482 |
| Lantus | 12 | $4,983 | $415 |
| Atorvastatin | 141 | $2,592 | $18 |
| Gabapentin | 58 | $1,825 | $31 |
| Duloxetine | 25 | $1,290 | $52 |
| Tamsulosin | 23 | $1,259 | $55 |
| Hydrocodone-Acetaminophen | 48 | $1,238 | $26 |
| Levothyroxine | 45 | $1,161 | $26 |
| Nateglinide | 12 | $839 | $70 |
| Ventolin Hfa | 14 | $793 | $57 |
| Metoprolol | 22 | $772 | $35 |
| Omeprazole | 51 | $751 | $15 |
| Voltaren | 15 | $745 | $50 |
| Valsartan | 13 | $732 | $56 |
| Polyethylene Glycol 3350 | 14 | $706 | $50 |
| Chlorthalidone | 12 | $700 | $58 |
| Potassium Chloride | 21 | $685 | $33 |
| Metformin | 70 | $653 | $9 |
| Losartan | 60 | $588 | $10 |
| Amlodipine Besylate | 85 | $529 | $6 |
| Lisinopril | 67 | $519 | $8 |
| Pantoprazole | 24 | $508 | $21 |
| Nystatin | 14 | $469 | $33 |
| Oxybutynin Chloride | 11 | $463 | $42 |
| Simvastatin | 48 | $370 | $8 |
| Allopurinol | 17 | $313 | $18 |
| Fluticasone Propionate | 26 | $271 | $10 |
| Hydrochlorothiazide | 33 | $269 | $8 |
| Clopidogrel | 17 | $250 | $15 |
| Hydralazine | 11 | $249 | $23 |
| Clonazepam | 31 | $230 | $7 |
| Atenolol | 46 | $228 | $5 |
| Tramadol | 25 | $213 | $9 |
| Furosemide | 29 | $164 | $6 |
| Paroxetine | 13 | $159 | $12 |
| Warfarin | 12 | $142 | $12 |
| Alendronate | 27 | $127 | $5 |
| Clonidine | 11 | $122 | $11 |
| Triamcinolone Acetonide | 13 | $107 | $8 |
| Methadone | 12 | $102 | $8 |
| Glipizide | 16 | $102 | $6 |
| Famotidine | 11 | $90 | $8 |
| Metoprolol | 16 | $86 | $5 |
| Alprazolam | 12 | $80 | $7 |
2015: 1 drug
| Atorvastatin | 13 | $257 | $20 |
Professional record
- NPI
- 1467742783
- Licence
- CA A122095California A122095: Current · expires 2028-07-31
- Trained
- University of Cincinnati College of Medicine, 2011 · 15 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-04-08
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd Ste 302, Palo Alto, CA, 94304